What clinical trials measure Clinical trials for weight loss medications track several outcomes: Percentage of body weight lost from baseline Proportion of participants achieving specific weight loss thresholds (10%, 15%, 20%, 25%+) Changes in metabolic markers (HbA1c, lipids, blood pressure) Safety and tolerability (adverse events, discontinuation rates) How much weight loss has retatrutide shown
Pretorius E, Kell DB
Visceral Fat Analysis: We focus on losing the dangerous fat surrounding the organs, which directly contributes to cardiovascular disease
It also has anti-inflammatory benefits
A 2025 JAMA article found that when you stop semaglutide or tirzepatide, even after use of up to one year, there is rapid regain of weight and reversal of cardiovascular benefits
Peptides enter circulation within 1530 minutes, producing a sharp plasma peak that research shows drops to sub-therapeutic levels within 3648 hours for small peptides under 2,000 daltons